Clinical research organisation (CRO) Icon has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes Icon the first CRO to completely integrate this ...
Adoption allows ICON to take full advantage of the Medidata "Data Experience," leveraging AI to unify data sources, standardize outputs, and reduce reconciliation efforts NEW YORK, March 20, ...
DUBLIN, January 30, 2025--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced the latest release of its Digital Platform. The platform ...
Icon has reached a preliminary agreement with Intel to use the Intel Pharma Analytics Platform in clinical trials. Launched in 2013, the Intel platform can continuously monitor and collect clinical ...
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results